摘要
目的构建丝聚合蛋白(FLG)基因RNA干扰(RNA interference,RNAi)慢病毒表达载体。方法设计针对人FLG基因的mRNA干扰靶序列,合成相应双链DNA,通过BamH I和EcoRI酶切后的PGLV/H1/GFP载体连接产生shRNA载体,并与pHelper 1.0、pHelper 2.0两种载体共转染293T细胞培养,获得重组慢病毒载体后,转染目的细胞,实现针对FLG基因的RNA干扰。结果经鉴定该实验的慢病毒载体,对人正常皮肤细胞HACAT干扰效果达75%-95%,以RNAi3的沉默效应最佳。结论重组的慢病毒载体为有关FLG基因的进一步研究奠定良好实验基础,并能广泛用于体内基因治疗及基因功能研究。
[ Objective ] To construct the lentiviral RNA interference (RNAi) vectors of the filaggrin (FLG) gene. [Methods] RNAi target sequences were designed according to the FLG gene sequences, then the double stranded DNA were synthesized, which was connected PGLV/H1 /GFP vector to constructed lentiviral vector with BamH Ⅰ and EcoR Ⅰ digested. 293T cells were co-transfected with pHelper 1.0, pHelper 2.0 and the plasmids to produce lentiviral particles, and the recombinant lentiviruses were transfected into HACAT cells to interfere FLG. [Results] It was approved that interference effect on the HACAT cells was 75% 95% reduction and RNAi3 had the best effect of gene silence. [ Conclusion ] The shRNA vector of the FLG gene established the experimental foundation for further research and might be widely used in the study of gene therapy and function.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2014年第8期8-11,共4页
China Journal of Modern Medicine
基金
国家自然科学基金(No:81101183)